Johnson & JohnsonvsSTAAR Surgical

JNJ and STAA stock compared: price, dividend, valuation and results, from SEC filings.

Johnson & Johnson (JNJ) has a market value of $672B and STAAR Surgical (STAA) $1.3B. Over the last year, with dividends, JNJ moved +45.4% and STAA -2.9%. The P/E is 41.7 for JNJ and 2,387.8 for STAA. Dividend yield: JNJ 1.89%, STAA none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    JNJ$672B

    STAA$1.3B

    JNJ is 531 times STAA

  • Revenue, 12 months

    JNJ$99.3B

    STAA$328M

    JNJ is 303 times STAA

  • Net income, 12 months

    JNJ$16.1B

    STAA$530.0K

    JNJ is 30,368 times STAA

  • Operating margin

    JNJ–

    STAA0.2%

  • ROIC

    JNJ12.4%

    STAA0.2%

    12.2 points apart

  • P/E

    JNJ41.7

    STAA2,387.8

    STAA is 57 times JNJ

  • Dividend yield

    JNJ1.9%

    STAA0.0%

    1.9 points apart

  • 5-year return

    JNJ+97.0%

    STAA-77.9%

    174.9 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

JNJ+97.0%

STAA-77.9%

10020020222023202420252026
Returns by period
PeriodJNJWith dividendsSTAAWith dividends
1 year since November 14, 2025+45.4%Price +42.2%-2.9%Price -2.9%
3 years since November 17, 2023+102.6%+26.5% a yearPrice +86.1%-26.6%-9.8% a yearPrice -26.6%
5 years since November 16, 2021+97.0%+14.5% a yearPrice +71.3%-77.9%-26.1% a yearPrice -77.9%
10 years since November 17, 2016+213.7%+12.1% a yearPrice +139.1%+142.3%+9.3% a yearPrice +142.3%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

JNJJohnson & JohnsonSTAASTAAR Surgical

Valuation

JNJSTAA
Valuation
Price$278.70$25.56
Market value$672B$1.3B
Enterprise value (EV)$699B$1.1B
P/E41.72,387.8
P/E, 5-year median21.9–
P/B8.23.4
EV/EBIT39.41,510.9
Free cash flow yield3.1%1.4%

Results and growth

JNJSTAA
Results and growth
Revenue, 12 months$99.3B$328M
Net income, 12 months$16.1B$530.0K
Free cash flow, 12 months$20.6B$18M
Earnings per share, 12 months$6.59$0.01
Revenue growth, year on year6.1%-23.7%
Revenue growth a year, past+2.7%over 5 years+7.9%over 5 years
EPS growth a year, past+14.9%over 5 years–

Margins and returns on capital

JNJSTAA
Margins and returns on capital
Gross margin67.6%73.6%
Operating margin–0.2%
Net margin16.2%0.2%
ROIC12.4%0.2%
ROE19.7%0.2%

Balance sheet

JNJSTAA
Balance sheet
Cash$17.2B$206M
Total debt$44.7B$34M
Net debt / EBITDA1.1-22.9
Interest cover18.0×–

Dividends and buybacks

JNJSTAA
Dividends and buybacks
Dividend yield1.9%–
Dividend per share, 12 months$5.28–
Dividend growth a year, past+5.3%over 5 years–
Buyback yield0.9%0.5%
Shareholder yield2.8%0.5%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: JNJ or STAA

Didn't find what you were looking for?

Ask us
Which is bigger, Johnson & Johnson or STAAR Surgical?

By market value, Johnson & Johnson ($672B) is about 530.7 times STAAR Surgical ($1.3B), at today's prices.

How did JNJ and STAA stock do over the last 10 years?

Since November 17, 2016, JNJ's price moved +139.1% and STAA's +142.3%. With dividends: JNJ +213.7% (+12.1% a year), STAA +142.3% (+9.3% a year). Past returns do not predict future ones.

Which pays the higher dividend, JNJ or STAA?

The dividend yield at today's price is 1.89% for Johnson & Johnson and none for STAAR Surgical. Over the last twelve months they paid $5.28 and – per share.

What is the P/E of JNJ and STAA?

At today's price, the P/E is 41.7 for JNJ and 2,387.8 for STAA. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Johnson & Johnson or STAAR Surgical?

Over the last twelve months, the net margin was 16.2% for Johnson & Johnson and 0.2% for STAAR Surgical, and the operating margin – and 0.2%. Revenue was $99.3B and $328M.

Which is the better investment, Johnson & Johnson or STAAR Surgical?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.